Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348504 · ClinicalTrials.gov registry record · Phase 3
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
A Phase 3 study of Acute Heart Failure, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,300
- Enrollment target
- 1
- Study location
NCT00348504: Completed Phase 3 study of Acute Heart Failure, sponsored by Abbott.
NCT00348504 is a Phase 3 study of Acute Heart Failure that has completed, run by Abbott. The registered enrollment target is 1,300 participants, roughly in line with the 1,290-participant average among 8 other Acute Heart Failure trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348504, a Phase 3 study of Acute Heart Failure, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.
Conditions Studied
Interventions
- DRUG levosimendan
- DRUG dobutamine
Study Locations (1)
Illinois
- Global Medical Information - Abbott - Abbott Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-06 |
| Phase | Phase 3 |
What the finished NCT00348504 record still lists
NCT00348504 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,290-participant average among 8 other Acute Heart Failure trials with a reported enrollment target.
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which levosimendan is the first listed.
NCT00348504 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00348504 about?
NCT00348504 is a clinical study titled "Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.". The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.
What is the current status of trial NCT00348504?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,300 participants. The study started on 2003-03. Estimated completion is 2005-06.
What conditions does trial NCT00348504 study?
This clinical trial studies the following conditions: Acute Heart Failure.
What interventions are being tested in trial NCT00348504?
The interventions under investigation include: levosimendan (DRUG), dobutamine (DRUG).
Who is sponsoring clinical trial NCT00348504?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00348504 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00348504's enrollment target sits among peer trials
1,300 3rd of 8 higher than 6 of 8 other Acute Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
COMPLETED · Phase 1
-
An Observational Study of the Functional Capacity of Heart Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia